Lv5
890 积分 2024-07-01 加入
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
8天前
已完结
Risankizumab: First Global Approval
18天前
已完结
Mirikizumab: First Approval
18天前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
18天前
已完结
P0848 Engineering and Development of a Novel Bispecific Antibody Targeting both TL1A and α4β7 for the Treatment of IBD
19天前
已完结
P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A
19天前
已完结
P0835 AI-guided generation and development of HXN-1001, a highly potent and half-life extended anti-TL1A antibody
19天前
已完结
Trends in the drug target landscape for autoimmune diseases
29天前
已完结
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
1个月前
已完结
皖公网安备34019202002308
